WHO reports progress in Ebola vaccine trials amid DRC outbreak
Story essentials
World Health Organization (WHO), DRC National Institute for Biomedical Research
Democratic Republic of the Congo (DRC)
July 2026
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policy- Earlier version 18/4/2026, 6:10:53 PM
WHO reports rising cases and deaths in the largest Ebola outbreak in DRC history. Clinical trials for Bundibugyo species vaccines are underway in the UK and Canada. A post-exposure prophylaxis trial is ongoing in Ituri province with over 25 participants. UN food agency warns that hunger is hindering the Ebola response.
Read next
Prioritized by shared people, places, and events.
Ebola outbreak in DRC disproportionately affects women and girls
Women and girls in the DRC are at high risk due to their roles as primary caregivers in families and communities. Over 54% of confirmed Ebola patients are women, and 51% of those aged 10-17 are girls. Economic impacts and lack of access to reproductive health services are worsening the crisis.